These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16962298)

  • 1. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; Campisi G; Florena AM; Ciach T
    Eur J Pharm Biopharm; 2007 Feb; 65(2):238-46. PubMed ID: 16962298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; Tripodo C; Florena AM; Campisi G
    Eur J Pharm Biopharm; 2007 Sep; 67(2):425-33. PubMed ID: 17451927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I.
    De Caro V; Giandalia G; Siragusa MG; Paderni C; Campisi G; Giannola LI
    Eur J Pharm Biopharm; 2008 Nov; 70(3):869-73. PubMed ID: 18647652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs.
    Campisi G; Giannola LI; Florena AM; De Caro V; Schumacher A; Göttsche T; Paderni C; Wolff A
    J Control Release; 2010 Aug; 145(3):214-20. PubMed ID: 20438777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transbuccal tablets of carbamazepine: formulation, release and absorption pattern.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; D'Angelo M; Lo Muzio L; Campisi G
    Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):21-31. PubMed ID: 16848984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A duplex "Gemini" prodrug of naltrexone for transdermal delivery.
    Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL
    J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa.
    Rai V; Tan HS; Michniak-Kohn B
    Int J Pharm; 2011 Jun; 411(1-2):92-7. PubMed ID: 21443939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrically enhanced and controlled drug delivery through buccal mucosa.
    Mościcka-Studzińska A; Czarnecka K; Ciach T
    Acta Pol Pharm; 2008; 65(6):767-9. PubMed ID: 19172864
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation.
    Campisi G; Paderni C; Saccone R; Siragusa MG; Lo Muzio L; Tripodo C; Giannola LI; Florena AM
    Int J Immunopathol Pharmacol; 2008; 21(4):903-10. PubMed ID: 19144275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects.
    Paderni C; Campisi G; Schumacher A; Göttsche T; Giannola LI; De Caro V; Wolff A
    Int J Pharm; 2013 Aug; 452(1-2):128-34. PubMed ID: 23644347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
    Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
    J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prospective in treatment of Parkinson's disease: studies on permeation of ropinirole through buccal mucosa.
    De Caro V; Giandalia G; Siragusa MG; Sutera FM; Giannola LI
    Int J Pharm; 2012 Jun; 429(1-2):78-83. PubMed ID: 22465630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vitro transbuccal drug delivery of ondansetron HCl.
    Hu L; Damaj BB; Martin R; Michniak-Kohn BB
    Int J Pharm; 2011 Feb; 404(1-2):66-74. PubMed ID: 21056647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate.
    Telò I; Tratta E; Guasconi B; Nicoli S; Pescina S; Govoni P; Santi P; Padula C
    Int J Pharm; 2016 Jun; 506(1-2):420-8. PubMed ID: 27113869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Permeation of buspirone hydrochloride across animal buccal mucosa and its mechanism].
    Du Q; Ping QN; Liu G
    Yao Xue Xue Bao; 2001 Aug; 36(8):621-4. PubMed ID: 12579943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro permeation of tetramethylpyrazine across porcine buccal mucosa.
    Liu C; Xu HN; Li XL
    Acta Pharmacol Sin; 2002 Sep; 23(9):792-6. PubMed ID: 12230946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release and permeation of oxytocin from a mucoadhesive buccal patch.
    Li C; Bhatt PP; Johnston TP
    Pharm Dev Technol; 1996 Dec; 1(4):357-64. PubMed ID: 9552319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers.
    Kulkarni U; Mahalingam R; Pather SI; Li X; Jasti B
    J Pharm Sci; 2009 Feb; 98(2):471-83. PubMed ID: 18506782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
    Oh DH; Chun KH; Jeon SO; Kang JW; Lee S
    Eur J Pharm Biopharm; 2011 Oct; 79(2):357-63. PubMed ID: 21683790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.